Genetic detection information processing method before embryo implantation based on three-generation sequencing

Through the third-generation sequencing technology, combined with the Pacific Biosciences or Oxford Nanopore Technologies platform, it can identify mutations in the embryo genome, solving the problem that the existing technology cannot detect single-gene diseases and chromosomal abnormalities simultaneously, achieving high resolution and long read length, and improving embryo implantation The accuracy and comprehensiveness of pre-genetic testing enhances the success rate of assisted reproductive technology.

CN118969087APending Publication Date: 2024-11-15THE NAVAL MEDICAL UNIV OF PLA
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410972811.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing preimplantation genetic testing technology cannot simultaneously detect single-gene diseases, chromosomal abnormalities and large fragment structural mutations, and there are problems with limited detection range and low resolution.

Method used

Using three-generation sequencing technology, through embryo biopsy, DNA extraction and amplification, library construction, sequencing and data analysis, combined with the third-generation sequencing platform of Pacific Biosciences or Oxford Nanopore Technologies, we can identify single nucleotide variants, copy number variants and structural variants in the embryo genome. Provide comprehensive genetic information.

Benefits of technology

It achieves high resolution and long reading length, and can simultaneously detect single-gene diseases, chromosomal abnormalities and large fragment structural mutations, improves the accuracy and comprehensiveness of pre-implantation genetic testing, and enhances the success rate of assisted reproductive technology.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118969087A_ABST
    Figure CN118969087A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of genetic detection, and discloses a genetic detection information processing method before embryo implantation based on three-generation sequencing, which has the advantages of high resolution and long read length: by utilizing the long read length advantage of the three-generation sequencing technology, the structural variation of a large fragment can be detected, and the defect of NGS is made up. And comprehensive detection: in combination with high accuracy and long reading length of three-generation sequencing, single-gene diseases, chromosome abnormality and large structural variation can be detected at the same time, and more comprehensive genetics information is provided. By accurately evaluating genetic risks of the embryos, healthy embryos can be selected for transplantation, and the success rate of the assisted reproduction technology is increased. The genetic detection information processing method before embryo implantation based on three-generation sequencing has the advantages of high resolution, long reading length, comprehensive detection and the like, provides more accurate and reliable genetic basis for embryo transplantation selection, and is expected to improve the success rate of assisted reproduction technology.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of genetic detection, and in particular relates to a method for processing information of pre-implantation genetic detection based on third-generation sequencing. Background Art

[0002] At present, preimplantation genetic testing (PGT) is mainly based on the second-generation sequencing technology (NGS), such as the Illumina platform. Although NGS has high throughput and relatively low cost, its read length is short and it is difficult to detect large fragment structural variations (SVs), such as duplications, inversions, and translocations. These SVs may be closely related to abnormal embryo development, genetic diseases, etc., so the application of NGS in PGT has certain limitations.

[0003] Another PGT method is based on array comparative genomic hybridization (aCGH). aCGH can detect chromosome copy number variations (CNVs), but its resolution is limited and it cannot detect point mutations and small indels associated with single gene diseases.

[0004] Through the above analysis, the problems and defects of the prior art are as follows:

[0005] The short read length of next-generation sequencing (NGS) makes it difficult to detect large structural variations (SVs).

[0006] Array comparative genomic hybridization (aCGH) has limited resolution and cannot detect point mutations and small indels associated with monogenic diseases.

[0007] Existing technologies are not able to detect single gene diseases, chromosomal abnormalities, and large structural variants simultaneously. Summary of the invention

[0008] In view of the problems existing in the prior art, the present invention provides a method for processing information of preimplantation genetic testing based on third-generation sequencing.

[0009] The present invention is implemented as follows: a method for processing information of preimplantation genetic testing based on third-generation sequencing comprises:

[0010] Step 1, Embryo Biopsy:

[0011] Obtaining a small number of cells from embryos cultured through in vitro fertilization;

[0012] Step 2, DNA extraction and amplification:

[0013] Extract DNA from embryonic cells and amplify it using multiple displacement amplification (MDA) or other whole genome amplification techniques to obtain sufficient DNA for sequencing;

[0014] Step 3, library construction:

[0015] The amplified DNA is fragmented and a library suitable for third-generation sequencing is constructed;

[0016] Step 4, third-generation sequencing:

[0017] The library was sequenced using the third-generation sequencing platform of Pacific Biosciences or Oxford Nanopore Technologies;

[0018] Step 5, data analysis:

[0019] Perform bioinformatics analysis on sequencing data, including alignment, variant detection, annotation, and identification of single nucleotide variants (SNVs), small insertions and deletions (Indels), CNVs, and SVs in the embryo genome;

[0020] Step 6, Genetic Diagnosis:

[0021] Based on the analysis results, the genetic risk of the embryo is assessed to provide a scientific basis for embryo transplantation selection.

[0022] Furthermore, the embryo biopsy:

[0023] Timing: Biopsy is usually performed at the 5th day of embryonic development, during the blastocyst stage, when there are more embryonic cells;

[0024] Methods: Laser-assisted biopsy technology was used to precisely cut and remove 5-10 trophectoderm cells under a microscope;

[0025] Quality control: Perform chromosome karyotype analysis or fluorescence in situ hybridization (FISH) on biopsied cells to ensure that the cell quantity and quality meet the requirements.

[0026] Further, the DNA extraction and amplification:

[0027] DNA extraction: A commercial DNA extraction kit was used to extract genomic DNA from biopsied cells;

[0028] Whole genome amplification (WGA):

[0029] Methods: Multiple displacement amplification (MDA) technology is preferred;

[0030] Quality control: qPCR or microarray technology is used to detect the concentration, uniformity and coverage of the amplified products.

[0031] Further, the library is constructed:

[0032] DNA fragmentation: Use enzyme digestion or ultrasonic fragmentation to fragment the amplified DNA to the required length, usually 10-20kb;

[0033] End repair and poly A addition: repair the ends of the DNA fragments and add a poly A tail to the 3' end;

[0034] Adapter ligation: connect the DNA fragments with sequencing adapters to the library adapters;

[0035] Quality control: qPCR or capillary electrophoresis is used to detect the concentration, fragment size distribution and adapter ligation efficiency of the library.

[0036] Further, the third generation sequencing:

[0037] Selection of sequencing platform: Choose Pacific Biosciences (PacBio) Sequel IIe or Oxford Nanopore Technologies (ONT) PromethION third-generation sequencing platform according to actual needs;

[0038] Sequencing mode: The PacBio platform can select the CCS (Circular Consensus Sequencing) mode to improve sequencing accuracy; the ONT platform can select the ultra-long read length mode, which is conducive to the detection of structural variations.

[0039] Further, the data analysis:

[0040] Data quality control: filter low-quality reads and remove adapter sequences;

[0041] Genome alignment: Align sequencing reads to the human reference genome, using commonly used software such as Minimap2 and NGMLR;

[0042] Variant Detection:

[0043] SNV and Indel: Detected using DeepVariant and Clair3 deep learning algorithms;

[0044] CNV: Detected using Control-FREEC and CNVnator software;

[0045] SV: detected using Sniffles and pbsv software;

[0046] Variant annotation: Annovar and VEP software were used to perform functional annotation on the detected variants and evaluate their pathogenicity.

[0047] Another object of the present invention is to provide a preimplantation genetic testing system based on third-generation sequencing, comprising:

[0048] Embryo biopsy module, used to obtain a small number of cells from embryos cultured in vitro; equipped with image recognition and automatic control functions;

[0049] DNA Extraction and Amplification Module for DNA preparation via integrated automated DNA extraction and whole genome amplification instrumentation;

[0050] The library construction module integrates automated DNA fragmentation, end repair, A addition, and adapter ligation to simplify the library construction process; it is compatible with a variety of third-generation sequencing library preparation kits and adapts to different sequencing platforms;

[0051] The third-generation sequencing module is used to match the PacBio Sequel IIe or ONT PromethION high-throughput third-generation sequencing platform to meet different testing needs; it integrates real-time data monitoring function to detect and handle abnormal situations;

[0052] Bioinformatics analysis module, which is used to automatically process data by integrating genome alignment, variation detection, and annotation analysis tools; it has multiple built-in variation detection algorithms and selects the optimal algorithm according to different variation types; it provides a visual interface to intuitively display the analysis results;

[0053] The genetic diagnosis module is used to integrate genetic databases and literature knowledge bases to provide reference for variant interpretation; it is equipped with an intelligent risk assessment model to assess embryo genetic risks based on variant information and patient background; it provides professional report interpretation and consulting services to assist clinical decision-making.

[0054] Another object of the present invention is to provide a computer device, which includes a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the method for processing information of pre-implantation genetic testing based on third-generation sequencing.

[0055] Another object of the present invention is to provide a computer-readable storage medium storing a computer program, which, when executed by a processor, enables the processor to perform the steps of the method for processing information of preimplantation genetic testing based on third-generation sequencing.

[0056] Another object of the present invention is to provide the information data processing terminal for implementing the pre-implantation genetic detection system based on third-generation sequencing.

[0057] In combination with the above technical solutions and the technical problems solved, the advantages and positive effects of the technical solutions to be protected by the present invention are as follows:

[0058] First, the present invention has high resolution and long read length: by utilizing the long read length advantage of the third-generation sequencing technology, it can detect structural variations of large fragments, making up for the shortcomings of NGS.

[0059] Comprehensive detection: Combining the high accuracy and long read length of third-generation sequencing, it can simultaneously detect single-gene diseases, chromosomal abnormalities and large structural variations, providing more comprehensive genetic information.

[0060] Improve the success rate of embryo implantation: By accurately assessing the genetic risk of the embryo, it helps to select healthy embryos for transplantation and improve the success rate of assisted reproductive technology.

[0061] The present invention provides a method for processing information of preimplantation genetic testing based on third-generation sequencing, which has the advantages of high resolution, long read length, and comprehensive detection. It provides a more accurate and reliable genetic basis for embryo transplantation selection and is expected to improve the success rate of assisted reproductive technology.

[0062] Second, the present invention provides a method for processing information of preimplantation genetic testing based on third-generation sequencing, which solves the shortcomings of the prior art in terms of accuracy and comprehensiveness of genetic testing. Traditional preimplantation genetic testing methods, such as first- and second-generation sequencing, have problems such as limited detection range, low resolution, and difficulty in fully identifying complex gene mutations. The present invention, by adopting third-generation sequencing technology, significantly improves the accuracy and comprehensiveness of the test, and can more accurately assess the genetic risk of the embryo.

[0063] First, the present invention obtains a small amount of cells from in vitro fertilized embryos by performing a biopsy at the blastocyst stage on the fifth day of embryonic development, and uses laser-assisted biopsy technology to accurately cut and remove 5-10 trophectoderm cells. The number of embryonic cells at this stage is relatively large, ensuring the representativeness and quality of the biopsy sample. In addition, by performing chromosome karyotype analysis or fluorescence in situ hybridization FISH detection on the biopsied cells, it is further ensured that the cell quantity and quality meet the requirements, providing a reliable basis for subsequent DNA extraction and amplification.

[0064] Secondly, the present invention uses multiple displacement amplification (MDA) or other whole genome amplification techniques to amplify DNA to obtain sufficient DNA for third-generation sequencing. Compared with traditional methods, this amplification technology can retain genomic information more comprehensively, reduce the deviations and errors that may be introduced during the amplification process, and thus improve the accuracy of sequencing. A library suitable for third-generation sequencing is constructed and sequenced using the third-generation sequencing platform of Pacific Biosciences or Oxford Nanopore Technologies, ensuring high throughput and high resolution of sequencing.

[0065] In terms of data analysis, the present invention uses bioinformatics analysis to compare, detect and annotate sequencing data, and can identify single nucleotide variations (SNVs), small insertions and deletions (Indels), copy number variations (CNVs) and structural variations (SVs) in the embryonic genome. This comprehensive data analysis method can not only detect common gene variations, but also identify complex genomic structural variations, thereby providing more comprehensive and accurate genetic information.

[0066] Finally, the present invention evaluates the genetic risk of embryos based on the results of bioinformatics analysis and provides a scientific basis for embryo transplantation selection. This method of processing information for preimplantation genetic testing based on third-generation sequencing significantly improves the accuracy and comprehensiveness of testing, solves the problems of limited detection range and low resolution in the prior art, and thus provides strong support for the early prevention of genetic diseases and the selection of healthy embryos, with important clinical application value and technological progress. BRIEF DESCRIPTION OF THE DRAWINGS

[0067] Figure 1 It is a flow chart of a method for processing information of preimplantation genetic testing based on third-generation sequencing provided in an embodiment of the present invention.

[0068] Figure 2 It is a flow chart of the DNA extraction and amplification method provided by an embodiment of the present invention.

[0069] Figure 3 It is a structural block diagram of a preimplantation genetic detection system based on third-generation sequencing provided in an embodiment of the present invention. DETAILED DESCRIPTION

[0070] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0071] The following are two specific examples of preimplantation genetic testing based on third-generation sequencing:

[0072] Example 1: Detection of single gene genetic diseases

[0073] 1) Embryo biopsy: At the blastocyst stage on the 5th day after in vitro fertilization, laser-assisted biopsy technology is used to precisely cut and remove 5-10 cells from the embryo's trophectoderm under a microscope. These cells will be used for subsequent genetic testing.

[0074] 2) DNA extraction and amplification: DNA is extracted from embryonic cells obtained from biopsy and whole genome amplification is performed using multiple displacement amplification (MDA) technology to obtain sufficient DNA for sequencing.

[0075] 3) Library construction and sequencing: The amplified DNA was fragmented and a library suitable for third-generation sequencing was constructed. Then, the library was sequenced using the third-generation sequencing platform of Pacific Biosciences.

[0076] 4) Data analysis: Bioinformatics analysis of sequencing data, including alignment, variant detection, annotation and other steps, is performed to identify whether there are variants in the embryonic genome that are associated with specific single-gene genetic diseases.

[0077] 5) Genetic diagnosis: Based on the analysis results, the genetic risk of the embryo is assessed. If the embryo does not carry a mutation associated with a specific single gene genetic disease, the embryo can be selected for transplantation.

[0078] Example 2: Detection of Chromosome Abnormalities

[0079] 1) Embryo biopsy and DNA extraction and amplification: The steps are the same as those in Example 1, biopsy cells from blastocyst-stage embryos, and DNA is extracted and amplified.

[0080] 2) Library construction and sequencing: A library suitable for third-generation sequencing was constructed and sequenced using the third-generation sequencing platform of Oxford Nanopore Technologies.

[0081] 3) Data analysis: Perform comprehensive chromosome analysis on the sequencing data, including detection of chromosome number and structural variations (such as translocations, inversions, etc.).

[0082] 4) Genetic diagnosis: Based on the analysis results, the chromosomal risk of the embryo is assessed. If the number and structure of chromosomes of the embryo are normal and there are no obvious abnormalities, the embryo can be selected for transplantation.

[0083] These two examples demonstrate the application of preimplantation genetic testing based on third-generation sequencing in different genetic risk assessments, providing a scientific basis for embryo transplantation and helping to reduce the risks of birth defects and genetic diseases.

[0084] like Figure 1 As shown, a method for processing information of preimplantation genetic testing based on third-generation sequencing provided by an embodiment of the present invention comprises the following steps:

[0085] S101, Embryo Biopsy:

[0086] Obtaining a small number of cells from embryos cultured through in vitro fertilization;

[0087] S102, DNA extraction and amplification:

[0088] Extract DNA from embryonic cells and amplify it using multiple displacement amplification (MDA) or other whole genome amplification techniques to obtain sufficient DNA for sequencing;

[0089] S103, library construction:

[0090] The amplified DNA is fragmented and a library suitable for third-generation sequencing is constructed;

[0091] S104, third generation sequencing:

[0092] The library was sequenced using the third-generation sequencing platform of Pacific Biosciences or Oxford Nanopore Technologies;

[0093] S105, Data Analysis:

[0094] Perform bioinformatics analysis on sequencing data, including alignment, variant detection, annotation, and identification of single nucleotide variants (SNVs), small insertions and deletions (Indels), CNVs, and SVs in the embryo genome;

[0095] S106, Genetic Diagnosis:

[0096] Based on the analysis results, the genetic risk of the embryo is assessed to provide a scientific basis for embryo transplantation selection.

[0097] Embryo biopsy provided in the embodiment of the present invention:

[0098] Timing: Biopsy is usually performed at the 5th day of embryonic development, during the blastocyst stage, when there are more embryonic cells;

[0099] Methods: Laser-assisted biopsy technology was used to precisely cut and remove 5-10 trophectoderm cells under a microscope;

[0100] Quality control: Perform chromosome karyotype analysis or fluorescence in situ hybridization (FISH) on biopsied cells to ensure that the cell quantity and quality meet the requirements.

[0101] like Figure 2 As shown, the DNA extraction and amplification provided by the embodiment of the present invention is:

[0102] S201, DNA extraction: Genomic DNA from biopsy cells was extracted using a commercial DNA extraction kit;

[0103] S202, whole genome amplification (WGA):

[0104] Methods: Multiple displacement amplification (MDA) technology was preferred;

[0105] Quality control: qPCR or microarray technology is used to detect the concentration, uniformity and coverage of the amplified products.

[0106] The library construction provided by the embodiment of the present invention is:

[0107] DNA fragmentation: Use enzyme digestion or ultrasonic fragmentation to fragment the amplified DNA to the required length, usually 10-20kb;

[0108] End repair and poly A addition: repair the ends of the DNA fragments and add a poly A tail to the 3' end;

[0109] Adapter ligation: connect the DNA fragments with sequencing adapters to the library adapters;

[0110] Quality control: qPCR or capillary electrophoresis is used to detect the concentration, fragment size distribution and adapter ligation efficiency of the library.

[0111] The third generation sequencing provided by the embodiment of the present invention:

[0112] Selection of sequencing platform: Choose Pacific Biosciences (PacBio) Sequel IIe or Oxford Nanopore Technologies (ONT) PromethION third-generation sequencing platform according to actual needs;

[0113] Sequencing mode: The PacBio platform can select the CCS (Circular Consensus Sequencing) mode to improve sequencing accuracy; the ONT platform can select the ultra-long read length mode, which is conducive to the detection of structural variations.

[0114] Data analysis provided by the embodiment of the present invention:

[0115] Data quality control: filter low-quality reads and remove adapter sequences;

[0116] Genome alignment: Align sequencing reads to the human reference genome, using commonly used software such as Minimap2 and NGMLR;

[0117] Variant Detection:

[0118] SNV and Indel: Detected using DeepVariant and Clair3 deep learning algorithms;

[0119] CNV: Detected using Control-FREEC and CNVnator software;

[0120] SV: detected using Sniffles and pbsv software;

[0121] Variant annotation: Annovar and VEP software were used to perform functional annotation on the detected variants and evaluate their pathogenicity.

[0122] like Figure 3 As shown, a preimplantation genetic detection system based on third-generation sequencing provided by an embodiment of the present invention includes:

[0123] Embryo biopsy module, used to obtain a small number of cells from embryos cultured in vitro; equipped with image recognition and automatic control functions;

[0124] DNA Extraction and Amplification Module for DNA preparation via integrated automated DNA extraction and whole genome amplification instrumentation;

[0125] The library construction module integrates automated DNA fragmentation, end repair, A addition, and adapter ligation to simplify the library construction process; it is compatible with a variety of third-generation sequencing library preparation kits and adapts to different sequencing platforms;

[0126] The third-generation sequencing module is used to match the PacBio Sequel IIe or ONT PromethION high-throughput third-generation sequencing platform to meet different testing needs; it integrates real-time data monitoring function to detect and handle abnormal situations;

[0127] Bioinformatics analysis module, which is used to automatically process data by integrating genome alignment, variation detection, and annotation analysis tools; it has multiple built-in variation detection algorithms and selects the optimal algorithm according to different variation types; it provides a visual interface to intuitively display the analysis results;

[0128] The genetic diagnosis module is used to integrate genetic databases and literature knowledge bases to provide reference for variant interpretation; it is equipped with an intelligent risk assessment model to assess embryo genetic risks based on variant information and patient background; it provides professional report interpretation and consulting services to assist clinical decision-making.

[0129] Another object of the present invention is to provide a computer device, which includes a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the method for processing information of pre-implantation genetic testing based on third-generation sequencing.

[0130] Another object of the present invention is to provide a computer-readable storage medium storing a computer program, which, when executed by a processor, enables the processor to perform the steps of the method for processing information of preimplantation genetic testing based on third-generation sequencing.

[0131] Another object of the present invention is to provide the information data processing terminal for implementing the pre-implantation genetic detection system based on third-generation sequencing.

[0132] The present invention is specifically implemented:

[0133] The following is a specific implementation plan for preimplantation genetic testing based on third-generation sequencing (TGS), including experimental procedures, technical details, and data analysis strategies:

[0134] 1. Embryo biopsy:

[0135] Timing: Biopsy is usually performed on the 5th day of embryonic development (blastocyst stage), when the number of embryonic cells is larger and the impact on embryonic development is smaller.

[0136] Methods: Laser-assisted biopsy technology was used to precisely cut and remove 5-10 trophectoderm cells under a microscope.

[0137] Quality control: Perform chromosome karyotype analysis or fluorescence in situ hybridization (FISH) on biopsied cells to ensure that the cell quantity and quality meet the requirements.

[0138] 2. DNA extraction and amplification:

[0139] DNA extraction: Genomic DNA from biopsy cells was extracted using a commercial DNA extraction kit.

[0140] Whole Genome Amplification (WGA):

[0141] Methods: Multiple displacement amplification (MDA) is preferred because of its high fidelity and uniformity. Other WGA techniques such as MALBAC can also be used.

[0142] Quality control: qPCR or microarray technology is used to detect the concentration, uniformity and coverage of the amplified products to ensure the quality of amplification.

[0143] 3. Library construction:

[0144] DNA fragmentation: Use enzymatic digestion or ultrasonic fragmentation to fragment the amplified DNA to the desired length (usually 10-20 kb).

[0145] End repair and poly A addition: Repair the ends of the DNA fragments and add a poly A tail to the 3' end.

[0146] Adapter ligation: Ligate the DNA fragments with sequencing adapters to the library adapters.

[0147] Quality control: qPCR or capillary electrophoresis is used to detect the concentration, fragment size distribution and adapter ligation efficiency of the library.

[0148] 4. Third generation sequencing:

[0149] Selection of sequencing platform: Select a third-generation sequencing platform such as Pacific Biosciences (PacBio) Sequel IIe or Oxford Nanopore Technologies (ONT) PromethION according to actual needs.

[0150] Sequencing mode: The PacBio platform can select the CCS (Circular Consensus Sequencing) mode to improve sequencing accuracy; the ONT platform can select the ultra-long read length mode, which is conducive to the detection of structural variations.

[0151] 5. Data Analysis:

[0152] Data quality control: filter low-quality reads and remove adapter sequences.

[0153] Genome alignment: Align sequencing reads to the human reference genome. Commonly used software include Minimap2, NGMLR, etc.

[0154] Variant Detection:

[0155] SNV and Indel: DeepVariant, Clair3 and other deep learning algorithms are used for detection.

[0156] CNV: Use Control-FREEC, CNVnator and other software for detection.

[0157] SV: Detected using Sniffles, pbsv and other software.

[0158] Variant annotation: Annovar, VEP and other software were used to perform functional annotation on the detected variants and evaluate their pathogenicity.

[0159] 6. Genetic diagnosis:

[0160] Pathogenicity assessment: The pathogenicity of the variant is assessed based on information such as variant type, location, frequency, and function, combined with genetic databases (such as ClinVar, HGMD) and literature reports.

[0161] Embryo risk assessment: Based on the detected pathogenic variants, the genetic risk of the embryo is assessed taking into account the genetic background and family history of the parents.

[0162] Embryo selection: Selecting embryos with low genetic risk for transfer to increase the success rate of assisted reproductive technology.

[0163] Note:

[0164] This solution is only an example. The specific operation steps and parameter settings may vary depending on the actual situation.

[0165] Before performing PGT, patients should be fully informed of the relevant risks and limitations, and their informed consent should be obtained.

[0166] PGT results are for clinical reference only, and the final embryo transfer decision should be based on the patient's specific circumstances and the doctor's professional judgment.

[0167] The following are two specific embodiments of the preimplantation genetic testing method based on third-generation sequencing (TGS):

[0168] Example 1: Detection of single gene genetic diseases (such as thalassemia)

[0169] Embryo biopsy: A biopsy is performed on the blastocyst stage embryo to obtain 5-10 trophectoderm cells.

[0170] DNA extraction and amplification: DNA was extracted using the Qiagen REPLI-g Single Cell Kit, and whole genome amplification was performed using MALBAC.

[0171] Library construction: The amplified product was fragmented to 15 kb and the library was constructed using PacBio SMRTbell Express Template Prep Kit 2.0.

[0172] Third-generation sequencing: CCS sequencing was performed on the PacBio Sequel IIe platform with an average sequencing depth of 30X.

[0173] Data Analysis:

[0174] The sequencing data were aligned to the human reference genome GRCh38 using Minimap2.

[0175] DeepVariant was used to detect SNVs and Indels, focusing on variants in thalassemia-related genes (such as HBA1, HBA2, and HBB).

[0176] VEP was used to annotate variants and assess their pathogenicity.

[0177] Genetic diagnosis:

[0178] Based on the detected mutations, combined with the parents' genotypes and family history, it is determined whether the embryo carries the thalassemia disease-causing gene.

[0179] Embryos that do not carry the disease-causing gene are selected for transplantation.

[0180] Example 2: Detection of chromosomal abnormalities and structural variations (such as balanced chromosomal translocations)

[0181] Embryo biopsy: A biopsy is performed on the blastocyst stage embryo to obtain 5-10 trophectoderm cells.

[0182] DNA extraction and amplification: DNA was extracted using the Qiagen REPLI-g Single Cell Kit, and whole genome amplification was performed using MDA.

[0183] Library construction: The amplified product was fragmented to 20 kb and the library was constructed using ONT Ligation Sequencing Kit SQK-LSK109.

[0184] Third-generation sequencing: Ultra-long read sequencing was performed on the ONT PromethION platform, with an average sequencing depth of 15X.

[0185] Data Analysis:

[0186] Sequencing data were aligned to the human reference genome GRCh38 using NGMLR.

[0187] Sniffles is used to detect SVs, focusing on structural variations such as balanced chromosomal translocations.

[0188] Control-FREEC was used to detect CNV and assess whether the chromosome number was abnormal.

[0189] Genetic diagnosis:

[0190] Based on the detected SV and CNV, combined with the karyotype analysis results of the parents, it is determined whether the embryo carries chromosomal abnormalities.

[0191] Chromosomally normal embryos were selected for transplantation.

[0192] Summarize:

[0193] The above examples demonstrate the application of PGT based on third-generation sequencing in detecting single-gene genetic diseases and chromosomal abnormalities. By selecting appropriate sequencing platforms, analysis tools and diagnostic strategies, more comprehensive genetic information can be provided for embryo transplantation, thereby improving the success rate of assisted reproductive technology.

[0194] Preimplantation genetic diagnosis system based on third-generation sequencing

[0195] The system consists of the following modules:

[0196] Embryo Biopsy Module:

[0197] Includes a laser microdissection system and a cell collection device for obtaining a small number of cells from embryos cultured in vitro.

[0198] Equipped with image recognition and automatic control functions to improve the accuracy and efficiency of biopsy operations.

[0199] DNA extraction and amplification module:

[0200] Integrate automated DNA extraction and whole genome amplification instruments to achieve fast, efficient and standardized DNA preparation.

[0201] A variety of WGA kits are built in, and the best solution can be selected according to different needs.

[0202] Equipped with a real-time monitoring system to monitor the amplification process and ensure the quality of amplification.

[0203] Library building blocks:

[0204] Integrates automated DNA fragmentation, end repair, A addition, and adapter ligation to simplify the library construction process.

[0205] Compatible with a variety of third-generation sequencing library preparation kits and flexibly adapt to different sequencing platforms.

[0206] Equipped with a quality control module to comprehensively evaluate the quality of the library.

[0207] Third generation sequencing module:

[0208] Optional high-throughput third-generation sequencing platforms such as PacBio Sequel IIe or ONT PromethION can be used to meet different detection needs.

[0209] Equipped with automated sample loading and data acquisition systems to improve sequencing efficiency.

[0210] Integrate real-time data monitoring function to detect and handle abnormal situations in time.

[0211] Bioinformatics analysis module:

[0212] Integrate genome alignment, variation detection, annotation and other analysis tools to realize automated data processing.

[0213] It has multiple built-in mutation detection algorithms, and the optimal algorithm can be selected according to different mutation types.

[0214] Provides a visual interface to intuitively display the analysis results.

[0215] Genetic Diagnosis Module:

[0216] Integrate genetic databases and literature knowledge bases to provide reference for variant interpretation.

[0217] Equipped with an intelligent risk assessment model to evaluate embryo genetic risks based on mutation information and patient background.

[0218] Provide professional report interpretation and consulting services to assist clinical decision-making.

[0219] System advantages:

[0220] Automation and high throughput: The system integrates multiple automation modules to achieve full process automation from embryo biopsy to genetic diagnosis, thus improving detection efficiency.

[0221] Accurate and comprehensive: Combined with third-generation sequencing technology, it can comprehensively detect single gene diseases, chromosomal abnormalities and structural variations, providing more accurate genetic information.

[0222] Intelligent and personalized: The system is equipped with intelligent analysis and diagnosis modules, which can provide personalized genetic counseling services based on the patient's specific circumstances.

[0223] Flexible and scalable: The system is modularly designed and can be flexibly configured according to different needs, making it easy to upgrade and expand.

[0224] Application scenarios:

[0225] Assisted Reproductive Center: used for pre-implantation genetic screening to improve the success rate of in vitro fertilization.

[0226] Prenatal Diagnosis Center: used for prenatal diagnosis and screening of fetal chromosomal abnormalities and genetic diseases.

[0227] Genetic Counseling Clinic: used for genetic counseling, assessing individual disease risks, and guiding reproductive decisions.

[0228] Scientific research institutions: used for genetic research to explore the relationship between human genome variation and disease.

[0229] Technical advances of the present invention:

[0230] High resolution and long read length: By taking advantage of the long read length of the third-generation sequencing technology, large-fragment structural variations can be detected, making up for the shortcomings of NGS.

[0231] Comprehensive detection: Combining the high accuracy and long read length of third-generation sequencing, it can simultaneously detect single-gene diseases, chromosomal abnormalities and large structural variations, providing more comprehensive genetic information.

[0232] Improve the success rate of embryo implantation: By accurately assessing the genetic risk of the embryo, it helps to select healthy embryos for transplantation and improve the success rate of assisted reproductive technology.

[0233] The present invention provides a method for processing information of preimplantation genetic testing based on third-generation sequencing, which has the advantages of high resolution, long read length, and comprehensive detection. It provides a more accurate and reliable genetic basis for embryo transplantation selection and is expected to improve the success rate of assisted reproductive technology.

[0234] The above description is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any modifications, equivalent substitutions and improvements made by any technician familiar with the technical field within the technical scope disclosed by the present invention and within the spirit and principle of the present invention should be covered by the protection scope of the present invention.

Claims

1. A method for processing information of preimplantation genetic testing based on third-generation sequencing, characterized in that: The following steps are involved: Step 1, Embryo Biopsy: Obtaining a small number of cells from embryos cultured through in vitro fertilization; Step 2, DNA extraction and amplification: Extract DNA from embryonic cells and amplify it using multiple displacement amplification (MDA) or other whole genome amplification techniques to obtain sufficient DNA for sequencing; Step 3, library construction: The amplified DNA is fragmented and a library suitable for third-generation sequencing is constructed; Step 4, third-generation sequencing: The library was sequenced using the third-generation sequencing platform of Pacific Biosciences or Oxford Nanopore Technologies; Step 5, data analysis: Perform bioinformatics analysis on sequencing data, including alignment, variant detection, annotation, and identification of single nucleotide variants (SNVs), small insertions and deletions (Indels), CNVs, and SVs in the embryo genome; Step 6, Genetic Diagnosis: Based on the analysis results, the genetic risk of the embryo is assessed to provide a scientific basis for embryo transplantation selection.

2. The method for processing information of preimplantation genetic testing based on third-generation sequencing according to claim 1, characterized in that: The embryo biopsy: Timing: Biopsy is usually performed at the 5th day of embryonic development, during the blastocyst stage, when there are more embryonic cells; Methods: Laser-assisted biopsy technology was used to precisely cut and remove 5-10 trophectoderm cells under a microscope; Quality control: Perform chromosome karyotype analysis or fluorescence in situ hybridization (FISH) on biopsied cells to ensure that the cell quantity and quality meet the requirements.

3. The method for processing information of preimplantation genetic testing based on third-generation sequencing according to claim 1, characterized in that: The DNA extraction and amplification: DNA extraction: A commercial DNA extraction kit was used to extract genomic DNA from biopsied cells; Whole genome amplification (WGA): Methods: Multiple displacement amplification (MDA) technology was preferred; Quality control: qPCR or microarray technology is used to detect the concentration, uniformity and coverage of the amplified products.

4. The method for processing information of preimplantation genetic testing based on third-generation sequencing according to claim 1, characterized in that: The library construction: DNA fragmentation: Use enzyme digestion or ultrasonic fragmentation to fragment the amplified DNA to the required length, usually 10-20kb; End repair and poly A addition: repair the ends of the DNA fragments and add a poly A tail to the 3' end; Adapter ligation: connect the DNA fragments with sequencing adapters to the library adapters; Quality control: qPCR or capillary electrophoresis is used to detect the concentration, fragment size distribution and adapter ligation efficiency of the library.

5. The method for processing information of preimplantation genetic testing based on third-generation sequencing according to claim 1, characterized in that: The third generation sequencing: Sequencing mode: The PacBio platform can select the CCS mode to improve sequencing accuracy; the ONT platform can select the ultra-long read length mode, which is conducive to the detection of structural variations.

6. The method for processing information of preimplantation genetic testing based on third-generation sequencing according to claim 1, characterized in that: The data analysis: Data quality control: filter low-quality reads and remove adapter sequences; Genome alignment: Align sequencing reads to the human reference genome, using commonly used software such as Minimap2 and NGMLR; Variant Detection: SNV and Indel: Detected using DeepVariant and Clair3 deep learning algorithms; CNV: Detected using Control-FREEC and CNVnator software; SV: detected using Sniffles and pbsv software; Variant annotation: Annovar and VEP software were used to perform functional annotation on the detected variants and evaluate their pathogenicity.

7. A preimplantation genetic testing system based on third-generation sequencing that implements the preimplantation genetic testing information processing method based on third-generation sequencing as described in any one of claims 1 to 6, characterized in that: The preimplantation genetic testing system based on third-generation sequencing includes: Embryo biopsy module, used to obtain a small number of cells from embryos cultured in vitro; equipped with image recognition and automatic control functions; DNA Extraction and Amplification Module for DNA preparation via integrated automated DNA extraction and whole genome amplification instrumentation; The library construction module integrates automated DNA fragmentation, end repair, A addition, and adapter ligation to simplify the library construction process; it is compatible with a variety of third-generation sequencing library preparation kits and adapts to different sequencing platforms; The third-generation sequencing module is used to match the PacBio Sequel IIe or ONT PromethION high-throughput third-generation sequencing platform to meet different testing needs; it integrates real-time data monitoring function to detect and handle abnormal situations; Bioinformatics analysis module, which is used to automatically process data by integrating genome alignment, variation detection, and annotation analysis tools; it has multiple built-in variation detection algorithms and selects the optimal algorithm according to different variation types; it provides a visual interface to intuitively display the analysis results; The genetic diagnosis module is used to integrate genetic databases and literature knowledge bases to provide reference for variant interpretation; it is equipped with an intelligent risk assessment model to assess embryo genetic risks based on variant information and patient background; it provides professional report interpretation and consulting services to assist clinical decision-making.

8. A computer device, characterized in that: The computer device includes a memory and a processor, the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the method for processing information of pre-implantation genetic testing based on third-generation sequencing as described in any one of claims 1-6.

9. A computer-readable storage medium storing a computer program, wherein when the computer program is executed by a processor, the processor executes the steps of the method for processing information of preimplantation genetic testing based on third-generation sequencing as described in any one of claims 1 to 6.

10. An information data processing terminal, characterized in that: The information data processing terminal is used to implement the pre-implantation genetic detection system based on third-generation sequencing as described in claim 7.

Citation Information

Cited By

  • Genetic integrated single molecule sequencing detection kit and system before embryo implantation

    CN122012701A

  • Embryo implantation prediction neural network model construction method and application, and embryo implantation prediction method and prediction model

    CN122761956A